Skip to content
Search

Latest Stories

Class 2 recall for Olopatadine eye drops

The Medicines and Healthcare products Regulatory Agency has issued a class 2 medicines recall notice for Olopatadine USV 1mg/ml eye drops.

Specific batches of this product are being recalled by USV UK Limited as a precautionary measure due to the identification of out of specification results for impurities during routine stability testing.


USV UK Limited are recalling the affected batches as a precautionary measure due to out of specification results for impurities during routine stability testing.

Batch NumberExpiry DatePack SizeFirst Distributed
3500020107/20235ml14 July 2021
3500020207/20235ml27 July 2021
3500020307/20235ml5 August 2021
3500020407/20235ml29 November 2021
3500020607/20235ml23 July 2021

While the company’s investigation is on-going, community pharmacy contractors should stop supplying the specified batches immediately, quarantine all remaining stock, and return it to their supplier using their supplier's approved process.

More For You

Fourth Shift: Investment in Innovative Medicines Crucial for NHS 10-Year Plan Success

Medicines should be viewed as an investment rather than a cost

gettyimages

ABPI wants to see a ‘fourth shift’ in NHS 10-Year Health Plan


The Association of the British Pharmaceutical Industry (ABPI) has called on the government to increase investment in innovative medicines and vaccines, describing it as a crucial “fourth shift” necessary to ensure the NHS is fit for the future.

Keep ReadingShow less
Asda pharmacy launches UK’s first adult earache service

Asda makes ear health more accessible for everyone

gettyimages

Asda pharmacy launches £25 adult earache service

British supermarket chain Asda has launched the “UK’s first” adult earache service, aiming to reduce the burden on NHS services by eliminating the need for a GP appointment.

Priced at £25, the service allows patients aged 18 and over to book same-day appointments with qualified Asda pharmacists at any of its 226 pharmacies in England.

Keep ReadingShow less
Dr Penelope Dash new chair of NHS England

Dr Penny Dash is currently the chair of the NHS North West London Integrated Care Board

parliamentlive

Dr Penelope Dash appointed as new chair of NHS England

Dr Penny Dash has been appointed as the next chair of NHS England following an open public appointment process.

She will succeed Richard Meddings, who is set to step down next month, and her four-year term begins on April 1, 2025.

Keep ReadingShow less
Nearly two-thirds of people think the NHS should be prioritised to receive more public spending in the future

Nearly two-thirds of people think the NHS should be prioritised to receive more public spending in the future

gettyimages

Over 70% public unaware of NHS 10-Year Health Plan – poll finds

Despite widespread promotion, nearly three-quarters (73%) of the English public remain unaware of the government’s 10-Year Health Plan for the NHS, according to new polling by the Health Foundation and Ipsos.

Once informed about the plan, just over a third (35%) expressed confidence that it would lead to improvements in the health service, while 59% remained unconvinced.

Keep ReadingShow less
Hospices receive £25 million for facility upgrades and refurbishments

The finding will help reform the palliative and end of life care system

gettyimages

Hospices receive £25 million for facility upgrades and refurbishments


The government has confirmed the release of £25 million for upgrades and refurbishments for hospices across England, as part of the biggest investment into hospices in a generation.

Keep ReadingShow less